Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alexion
Pharma
Health plan sues AZ's Alexion over 'fraudulent' Soliris patents
Nonprofit health plan EmblemHealth claims that AstraZeneca's Alexion unit fraudulently won extra patents on rare disease blockbuster Soliris.
Zoey Becker
Apr 17, 2025 10:50am
Arrowhead, Zevra fire up campaigns for Rare Disease Day 2025
Feb 28, 2025 10:18am
AZ slashes CEO Pascal Soriot's pay by 16% to $18.5M in 2024
Feb 19, 2025 8:20am
AZ loses $130M to Syntimmune shareholders in post-merger suit
Sep 9, 2024 11:43am
Amgen grabs FDA thumbs-up for Soliris biosim, eyes 2025 launch
May 29, 2024 10:26am
AZ's Alexion debuts short film highlighting NMOSD community
Apr 18, 2024 2:16pm
